Viewing Study NCT06394492


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2025-12-26 @ 6:47 PM
Study NCT ID: NCT06394492
Status: RECRUITING
Last Update Posted: 2024-08-09
First Post: 2024-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module